GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Cash & Current Investments (2009 - 2026)

Updated

Gsk (GSK) reported Cash & Current Investments of $3.92 billion for the quarter ended Sep 30, 2026, down 11.8% from $4.44 billion a year earlier and down 4.8% from the prior quarter.

Analysis

Gsk (GSK) Cash & Current Investments (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk posted Cash & Current Investments of $4.59 billion, down 6.1% from the prior year.

  • Cash & Current Investments has a five-year compound annual growth rate of -12.0% (years ended Dec 2020 to Dec 2025).
  • By year, Cash & Current Investments came in at $4.88 billion in the year ended Dec 31, 2024 (+28.8%), $3.79 billion in the year ended Dec 31, 2023 (-17.0%), $4.57 billion in the year ended Dec 31, 2022 (-21.9%) and $5.85 billion in the year ended Dec 31, 2021 (-32.6%).
  • The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Cash & Current Investments since the quarter ended Jun 30, 2024.
  • Year over year, Cash & Current Investments has now declined in each of the last four quarters, with growth averaging 8.8% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was the quarter ended Mar 31, 2023 (growth of 627.4%); the low point was the quarter ended Mar 31, 2022 (a decline of 92.4%).
  • Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at $4.12 billion (quarter ended Jun 30, 2026), $4.54 billion (quarter ended Mar 31, 2026) and $4.59 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.23 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 10.77 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 505.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 7.94 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 14.27 Bn
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn 3.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.92 Bn
Jun 30, 2026 4.12 Bn
Mar 31, 2026 4.54 Bn
Dec 31, 2025 4.59 Bn
Sep 30, 2025 4.44 Bn
Jun 30, 2025 4.97 Bn
Mar 31, 2025 5.80 Bn
Dec 31, 2024 4.88 Bn
Sep 30, 2024 4.30 Bn
Jun 30, 2024 3.77 Bn
Mar 31, 2024 3.55 Bn
Dec 31, 2023 3.79 Bn
Sep 30, 2023 3.96 Bn
Jun 30, 2023 4.10 Bn
Mar 31, 2023 3.66 Bn
Dec 31, 2022 4.57 Bn
Sep 30, 2022 4.11 Bn
Jun 30, 2022 7.92 Bn
Mar 31, 2022 503.22 Mn
Dec 31, 2021 5.85 Bn
API Access

Gsk Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY